These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 39304880)

  • 1. Educational differences in years lived with disability due to mental and substance use disorders: a cohort study using nationwide Norwegian and Danish registries.
    Weye NO; Plana-Ripoll O; Baravelli CM; Agardh EE; van der Velde L; Kinge JM; Knudsen AKS
    BMC Public Health; 2024 Sep; 24(1):2576. PubMed ID: 39304880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Register-based metrics of years lived with disability associated with mental and substance use disorders: a register-based cohort study in Denmark.
    Weye N; Santomauro DF; Agerbo E; Christensen MK; Iburg KM; Momen NC; Mortensen PB; Pedersen CB; Whiteford HA; McGrath JJ; Plana-Ripoll O
    Lancet Psychiatry; 2021 Apr; 8(4):310-319. PubMed ID: 33743882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Disease and Injury Incidence and Prevalence Collaborators
    Lancet; 2018 Nov; 392(10159):1789-1858. PubMed ID: 30496104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Disease and Injury Incidence and Prevalence Collaborators
    Lancet; 2017 Sep; 390(10100):1211-1259. PubMed ID: 28919117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.
    Whiteford HA; Degenhardt L; Rehm J; Baxter AJ; Ferrari AJ; Erskine HE; Charlson FJ; Norman RE; Flaxman AD; Johns N; Burstein R; Murray CJ; Vos T
    Lancet; 2013 Nov; 382(9904):1575-86. PubMed ID: 23993280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Mental Disorders Collaborators
    Lancet Psychiatry; 2022 Feb; 9(2):137-150. PubMed ID: 35026139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
    Global Burden of Disease Study 2013 Collaborators
    Lancet; 2015 Aug; 386(9995):743-800. PubMed ID: 26063472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.
    Vos T; Flaxman AD; Naghavi M; Lozano R; Michaud C; Ezzati M; Shibuya K; Salomon JA; Abdalla S; Aboyans V; Abraham J; Ackerman I; Aggarwal R; Ahn SY; Ali MK; Alvarado M; Anderson HR; Anderson LM; Andrews KG; Atkinson C; Baddour LM; Bahalim AN; Barker-Collo S; Barrero LH; Bartels DH; Basáñez MG; Baxter A; Bell ML; Benjamin EJ; Bennett D; Bernabé E; Bhalla K; Bhandari B; Bikbov B; Bin Abdulhak A; Birbeck G; Black JA; Blencowe H; Blore JD; Blyth F; Bolliger I; Bonaventure A; Boufous S; Bourne R; Boussinesq M; Braithwaite T; Brayne C; Bridgett L; Brooker S; Brooks P; Brugha TS; Bryan-Hancock C; Bucello C; Buchbinder R; Buckle G; Budke CM; Burch M; Burney P; Burstein R; Calabria B; Campbell B; Canter CE; Carabin H; Carapetis J; Carmona L; Cella C; Charlson F; Chen H; Cheng AT; Chou D; Chugh SS; Coffeng LE; Colan SD; Colquhoun S; Colson KE; Condon J; Connor MD; Cooper LT; Corriere M; Cortinovis M; de Vaccaro KC; Couser W; Cowie BC; Criqui MH; Cross M; Dabhadkar KC; Dahiya M; Dahodwala N; Damsere-Derry J; Danaei G; Davis A; De Leo D; Degenhardt L; Dellavalle R; Delossantos A; Denenberg J; Derrett S; Des Jarlais DC; Dharmaratne SD; Dherani M; Diaz-Torne C; Dolk H; Dorsey ER; Driscoll T; Duber H; Ebel B; Edmond K; Elbaz A; Ali SE; Erskine H; Erwin PJ; Espindola P; Ewoigbokhan SE; Farzadfar F; Feigin V; Felson DT; Ferrari A; Ferri CP; Fèvre EM; Finucane MM; Flaxman S; Flood L; Foreman K; Forouzanfar MH; Fowkes FG; Franklin R; Fransen M; Freeman MK; Gabbe BJ; Gabriel SE; Gakidou E; Ganatra HA; Garcia B; Gaspari F; Gillum RF; Gmel G; Gosselin R; Grainger R; Groeger J; Guillemin F; Gunnell D; Gupta R; Haagsma J; Hagan H; Halasa YA; Hall W; Haring D; Haro JM; Harrison JE; Havmoeller R; Hay RJ; Higashi H; Hill C; Hoen B; Hoffman H; Hotez PJ; Hoy D; Huang JJ; Ibeanusi SE; Jacobsen KH; James SL; Jarvis D; Jasrasaria R; Jayaraman S; Johns N; Jonas JB; Karthikeyan G; Kassebaum N; Kawakami N; Keren A; Khoo JP; King CH; Knowlton LM; Kobusingye O; Koranteng A; Krishnamurthi R; Lalloo R; Laslett LL; Lathlean T; Leasher JL; Lee YY; Leigh J; Lim SS; Limb E; Lin JK; Lipnick M; Lipshultz SE; Liu W; Loane M; Ohno SL; Lyons R; Ma J; Mabweijano J; MacIntyre MF; Malekzadeh R; Mallinger L; Manivannan S; Marcenes W; March L; Margolis DJ; Marks GB; Marks R; Matsumori A; Matzopoulos R; Mayosi BM; McAnulty JH; McDermott MM; McGill N; McGrath J; Medina-Mora ME; Meltzer M; Mensah GA; Merriman TR; Meyer AC; Miglioli V; Miller M; Miller TR; Mitchell PB; Mocumbi AO; Moffitt TE; Mokdad AA; Monasta L; Montico M; Moradi-Lakeh M; Moran A; Morawska L; Mori R; Murdoch ME; Mwaniki MK; Naidoo K; Nair MN; Naldi L; Narayan KM; Nelson PK; Nelson RG; Nevitt MC; Newton CR; Nolte S; Norman P; Norman R; O'Donnell M; O'Hanlon S; Olives C; Omer SB; Ortblad K; Osborne R; Ozgediz D; Page A; Pahari B; Pandian JD; Rivero AP; Patten SB; Pearce N; Padilla RP; Perez-Ruiz F; Perico N; Pesudovs K; Phillips D; Phillips MR; Pierce K; Pion S; Polanczyk GV; Polinder S; Pope CA; Popova S; Porrini E; Pourmalek F; Prince M; Pullan RL; Ramaiah KD; Ranganathan D; Razavi H; Regan M; Rehm JT; Rein DB; Remuzzi G; Richardson K; Rivara FP; Roberts T; Robinson C; De Leòn FR; Ronfani L; Room R; Rosenfeld LC; Rushton L; Sacco RL; Saha S; Sampson U; Sanchez-Riera L; Sanman E; Schwebel DC; Scott JG; Segui-Gomez M; Shahraz S; Shepard DS; Shin H; Shivakoti R; Singh D; Singh GM; Singh JA; Singleton J; Sleet DA; Sliwa K; Smith E; Smith JL; Stapelberg NJ; Steer A; Steiner T; Stolk WA; Stovner LJ; Sudfeld C; Syed S; Tamburlini G; Tavakkoli M; Taylor HR; Taylor JA; Taylor WJ; Thomas B; Thomson WM; Thurston GD; Tleyjeh IM; Tonelli M; Towbin JA; Truelsen T; Tsilimbaris MK; Ubeda C; Undurraga EA; van der Werf MJ; van Os J; Vavilala MS; Venketasubramanian N; Wang M; Wang W; Watt K; Weatherall DJ; Weinstock MA; Weintraub R; Weisskopf MG; Weissman MM; White RA; Whiteford H; Wiersma ST; Wilkinson JD; Williams HC; Williams SR; Witt E; Wolfe F; Woolf AD; Wulf S; Yeh PH; Zaidi AK; Zheng ZJ; Zonies D; Lopez AD; Murray CJ; AlMazroa MA; Memish ZA
    Lancet; 2012 Dec; 380(9859):2163-96. PubMed ID: 23245607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    GBD 2021 Diseases and Injuries Collaborators
    Lancet; 2024 May; 403(10440):2133-2161. PubMed ID: 38642570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The burden of headache disorders in the Eastern Mediterranean Region, 1990-2016: findings from the Global Burden of Disease study 2016.
    Vosoughi K; Stovner LJ; Steiner TJ; Moradi-Lakeh M; Fereshtehnejad SM; Farzadfar F; Heydarpour P; Malekzadeh R; Naghavi M; Sahraian MA; Sepanlou SG; Tehrani-Banihashemi A; Majdzadeh R; Feigin VL; Vos T; Mokdad AH; Murray CJL
    J Headache Pain; 2019 Apr; 20(1):40. PubMed ID: 31023215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of substance use disorders among people in Norwegian, Danish and Swedish prisons: A multi-national cohort study, 2010-19.
    Bukten A; Virtanen S; Hesse M; Thylstrup B; Kvamme TL; Seid AK; Chang Z; Skjærvø I; Tverborgvik T; Stavseth MR
    Addiction; 2024 Jul; 119(7):1264-1275. PubMed ID: 38529890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The global burden of mental, neurological and substance use disorders: an analysis from the Global Burden of Disease Study 2010.
    Whiteford HA; Ferrari AJ; Degenhardt L; Feigin V; Vos T
    PLoS One; 2015; 10(2):e0116820. PubMed ID: 25658103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The burden of mental disorders across the states of India: the Global Burden of Disease Study 1990-2017.
    India State-Level Disease Burden Initiative Mental Disorders Collaborators
    Lancet Psychiatry; 2020 Feb; 7(2):148-161. PubMed ID: 31879245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disability-adjusted Life Years (DALYs) for Mental and Substance Use Disorders in the Korean Burden of Disease Study 2012.
    Lim D; Lee WK; Park H
    J Korean Med Sci; 2016 Nov; 31 Suppl 2(Suppl 2):S191-S199. PubMed ID: 27775257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depressive disorders in Brazil: results from the Global Burden of Disease Study 2017.
    Bonadiman CSC; Malta DC; de Azeredo Passos VM; Naghavi M; Melo APS
    Popul Health Metr; 2020 Sep; 18(Suppl 1):6. PubMed ID: 32993670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 DALYs and HALE Collaborators
    Lancet; 2018 Nov; 392(10159):1859-1922. PubMed ID: 30415748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence and burden of mental and substance use disorders in Australia: Findings from the Global Burden of Disease Study 2015.
    Ciobanu LG; Ferrari AJ; Erskine HE; Santomauro DF; Charlson FJ; Leung J; Amare AT; Olagunju AT; Whiteford HA; Baune BT
    Aust N Z J Psychiatry; 2018 May; 52(5):483-490. PubMed ID: 29325437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Mental Disorder in Childhood and Adolescence With Subsequent Educational Achievement.
    Dalsgaard S; McGrath J; Østergaard SD; Wray NR; Pedersen CB; Mortensen PB; Petersen L
    JAMA Psychiatry; 2020 Aug; 77(8):797-805. PubMed ID: 32211833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A heavy burden on young minds: the global burden of mental and substance use disorders in children and youth.
    Erskine HE; Moffitt TE; Copeland WE; Costello EJ; Ferrari AJ; Patton G; Degenhardt L; Vos T; Whiteford HA; Scott JG
    Psychol Med; 2015 May; 45(7):1551-63. PubMed ID: 25534496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Burden of disease attributable to mental and substance use disorders in Brazil: Global Burden of Disease Study, 1990 and 2015.
    Bonadiman CSC; Passos VMA; Mooney M; Naghavi M; Melo APS
    Rev Bras Epidemiol; 2017 May; 20Suppl 01(Suppl 01):191-204. PubMed ID: 28658383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.